Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001088875-24-000044
Filing Date
2024-01-29
Accepted
2024-01-29 11:52:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 Adaptimmune29122023.txt SC 13G/A 9799
  Complete submission text file 0001088875-24-000044.txt   11526
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13G/A

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88833 | Film No.: 24571799
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)